myRocky Review

myRocky: a brand-name-only path to GLP-1s, at a brand-name price

myRocky is one of the few telehealth platforms that will put real, FDA-approved semaglutide and tirzepatide in your hands — Ozempic, Wegovy, and Mounjaro by their actual brand names — with no compounded substitutes anywhere on the menu. If avoiding compounded GLP-1s is your top priority and you're paying out of pocket, that's a genuinely meaningful offer. But you pay dearly for it: by the time you add up the fees and the medication, myRocky lands near full retail. This is a service for a specific, well-funded shopper, not a budget alternative.

How the pricing actually stacks up

This is the part to understand before anything else, because myRocky's pricing is layered rather than a single flat number. There are three separate charges: a one-time initial consultation fee, a recurring monthly program fee on top of that, and then the medication itself, which runs about $1409 a month for brand Ozempic. Add it together and you're looking at roughly fifteen hundred dollars a month all-in for the first month, then the program fee plus medication after that.

For perspective, the category median we track sits at $170 a month — myRocky charges many multiples of that. The reason is simple: most affordable telehealth weight-loss services dispense compounded GLP-1s, and myRocky deliberately doesn't. You are paying close to pharmacy-counter list price for the brand vials, with the consult and program fees layered on top. There is no teaser or discounted first month to soften the entry.

• Initial consultation: a one-time intake fee to get evaluated and prescribed
• Program fee: a separate recurring monthly charge for the ongoing service
• Medication: about $1409 a month for brand Ozempic, Wegovy, or Mounjaro
• No compounded tier — there is no cheaper option to step down to

The medications: real brands, no compounding

myRocky carries the three brand GLP-1s most people are searching for: Ozempic and Wegovy (both semaglutide) and Mounjaro (tirzepatide). These are the genuine, FDA-approved pens from Novo Nordisk and Eli Lilly — not a pharmacy-mixed version. For patients who've read the headlines about compounded-drug recalls and dosing errors and simply don't want that risk, this is the entire appeal of the platform in one sentence. What you see is what the manufacturer makes.

The trade-off is rigidity. Because there's no compounded line, there's no lower-cost lever to pull if the brand price is out of reach. You're locked into the branded supply chain and its price, full stop.

The Canadian wrinkle worth knowing about

Here's what genuinely sets myRocky apart from the typical US telehealth shop, and it cuts both ways: the company is Canadian. It operates as Rocky Health Inc. out of Mississauga, Ontario, and the pharmacy listed on its filings is Rocky Pharmacy, a Canadian community pharmacy in the same city. The brand names, the LegitScript verification, and a published 42-state footprint all check out — but exactly how a US patient's prescription gets written by a US-licensed prescriber and fulfilled into your state is not spelled out clearly on the public-facing pages.

This isn't a red flag of wrongdoing — it's a transparency gap. Before you hand over money, it's worth confirming directly with myRocky that the clinician treating you holds an active license in your state and that your medication ships from a US-authorized fulfillment point. Reputable cross-border operations exist; you just want the specifics in writing for your own state.

More than weight loss on one login

myRocky isn't a single-purpose GLP-1 shop. It's a multi-product platform that also handles sexual health, hair loss, and mental health under one subscription. If you're already the kind of person who'd rather manage several telehealth needs in one place — one login, one billing relationship — that consolidation has real convenience value. For someone who only wants weight-loss care, it's neither here nor there.

Who should choose it, and who should skip it

Choose myRocky if brand-name authenticity is non-negotiable for you, you're paying cash, and the all-in cost simply isn't the deciding factor. It's also a reasonable fit if you live in one of its 42 covered states and value bundling weight-loss care with other treatments.

Skip it if price matters at all. At roughly $1409 a month for the medication before fees, you're paying near retail — and the manufacturers themselves now undercut that directly: Novo Nordisk's cash program lists the Wegovy pen for a few hundred dollars a month, and Lilly's direct channel prices Zepbound well below the brand figure here. Cost-sensitive shoppers, and anyone open to a vetted compounded option, will do dramatically better elsewhere.

Trust and oversight

myRocky carries a LegitScript certification, which is a real, third-party signal that it operates as a legitimate pharmacy and telehealth business — not a fly-by-night storefront. There are no FDA warning letters on file in our record, and dispensing genuine brand product removes the compounding-quality questions that hang over cheaper rivals. We rate our confidence in this provider as medium, and the reason is narrow and specific: the Canadian corporate structure plus the unclear US-fulfillment chain. Everything we could verify — pricing, state coverage, brand offerings, certification — checked out verbatim. You can see how we weigh these factors in our scoring methodology.

Bottom line

myRocky does one thing clearly: it sells real, brand-name GLP-1s through a certified, multi-product telehealth platform, with zero compounding. If that's exactly what you want and money is no object, it delivers. But the stacked fees and near-retail medication price make it one of the most expensive ways to get on a GLP-1, and the Canadian incorporation leaves a fulfillment-transparency question you should resolve before paying. For most people, the manufacturers' own cash programs or a vetted lower-cost provider will be the smarter call — myRocky is a premium, niche choice, not a default one.

If you're weighing alternatives, Brightmeds ($325/month) and bmiMD ($99/month) are among the closest options we track to myRocky.